Advertisement

Table of Contents

October 17, 2013; 122 (16)

INSIDE BLOOD

BLOOD WORK

PLENARY PAPER

REVIEW ARTICLE

  • NETosis: how vital is it?
    Bryan G. Yipp and Paul Kubes

BLOOD CONSULT

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells
    Stephanie Beurlet, Nader Omidvar, Petra Gorombei, Patricia Krief, Carole Le Pogam, Niclas Setterblad, Pierre de la Grange, Christophe Leboeuf, Anne Janin, Maria-Elena Noguera, Florence Hervatin, Laure Sarda-Mantel, Marina Konopleva, Michael Andreeff, Andrea W. Tu, Alice C. Fan, Dean W. Felsher, Anthony Whetton, Marika Pla, Robert West, Pierre Fenaux, Christine Chomienne and Rose Ann Padua
  • Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
    Anuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, Amit Sharma, Haiyang Yun, Kerstin Görlich, Martin Wichmann, Adrian Schwarzer, Matthias Preller, Felicitas Thol, Johann Meyer, Reinhard Haemmerle, Eduard A. Struys, Erwin E. Jansen, Ute Modlich, Zhixiong Li, Laura M. Sly, Robert Geffers, Robert Lindner, Dietmar J. Manstein, Ulrich Lehmann, Jürgen Krauter, Arnold Ganser and Michael Heuser
  • Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia
    Yi Zhang, Kristina Owens, Layla Hatem, Carolyn H. Glass, Kannan Karuppaiah, Fernando Camargo and Archibald S. Perkins

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

VASCULAR BIOLOGY

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS